BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 33455503)

  • 1. Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin.
    Chedik L; Bruyere A; Le Vee M; Stieger B; Denizot C; Parmentier Y; Potin S; Fardel O
    PLoS One; 2017; 12(1):e0169480. PubMed ID: 28099443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).
    Ceckova M; Reznicek J; Deutsch B; Fromm MF; Staud F
    PLoS One; 2018; 13(8):e0202706. PubMed ID: 30114293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins.
    Minematsu T; Giacomini KM
    Mol Cancer Ther; 2011 Mar; 10(3):531-9. PubMed ID: 21252289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions.
    Gessner A; Müller F; Wenisch P; Heinrich MR; König J; Stopfer P; Fromm MF
    Clin Pharmacol Ther; 2023 Nov; 114(5):1058-1072. PubMed ID: 37540045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine.
    Vignaux PA; Lane TR; Puhl AC; Hau RK; Wright SH; Cherrington NJ; Ekins S
    ACS Omega; 2023 Apr; 8(13):12532-12537. PubMed ID: 37033868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions of niclosamide in rats: Involvement of organic anion transporters 1 and 3 and organic cation transporter 2.
    Kang MJ; Kim MJ; Kim A; Koo TS; Lee KR; Chae YJ
    Chem Biol Interact; 2024 Feb; 390():110886. PubMed ID: 38280639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ABC and SLC Transporters: The Culprit Responsible for Unspecific PSMA-617 Uptake?
    Taş H; Bakos G; Bauder-Wüst U; Schäfer M; Remde Y; Roscher M; Benešová-Schäfer M
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors.
    Alim K; Moreau A; Bruyère A; Jouan E; Denizot C; Nies AT; Parmentier Y; Fardel O
    Fundam Clin Pharmacol; 2021 Oct; 35(5):919-929. PubMed ID: 33523504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to "False" Decreases in Renal Function.
    Chen MF; Harada G; Liu D; DeMatteo R; Falcon C; Wilhelm C; Kris MG; Drilon A; Gutgarts V
    J Thorac Oncol; 2024 Jan; 19(1):153-159. PubMed ID: 37748692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors.
    Jouan E; Moreau A; Bruyere A; Alim K; Denizot C; Parmentier Y; Fardel O
    Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):625-635. PubMed ID: 34275128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporter-mediated Natural Product-Drug Interactions.
    Bi Y; Wang X; Ding H; He F; Han L; Zhang Y
    Planta Med; 2023 Feb; 89(2):119-133. PubMed ID: 35304735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced
    Koepsell H
    Expert Opin Drug Metab Toxicol; 2021 Jun; 17(6):635-653. PubMed ID: 33896325
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential
    Bruyère A; Le Vée M; Jouan E; Molez S; Nies AT; Fardel O
    Xenobiotica; 2021 Apr; 51(4):467-478. PubMed ID: 33455503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
    van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
    Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.